This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-183-5p | ABAT | 6.62 | 0 | 0.06 | 0.94069 | MirTarget | -0.16 | 0.00206 | NA | |
2 | hsa-let-7a-3p | ABCA1 | 0.83 | 0.04681 | 0.72 | 0.28064 | mirMAP; miRNATAP | -0.23 | 0.01252 | NA | |
3 | hsa-miR-183-5p | ABCA1 | 6.62 | 0 | 0.72 | 0.28064 | MirTarget; miRNATAP | -0.15 | 0.00066 | 26935154 | MiR 183 functions as an oncogene by targeting ABCA1 in colon cancer; We found that miR-183 targets the 3'UTR of ABCA1 mRNA; Subsequent experiments confirmed that miR-183 degraded ABCA1 mRNA in the colon cancer cells; Thus we conclude that miR-183 promotes proliferation and inhibits apoptosis by degrading ABCA1 in colon cancer |
4 | hsa-let-7a-3p | ABCA5 | 0.83 | 0.04681 | 0.37 | 0.51209 | mirMAP | -0.2 | 0.01113 | NA | |
5 | hsa-let-7f-1-3p | ABCA5 | 1.62 | 0.00069 | 0.37 | 0.51209 | mirMAP | -0.17 | 0.01029 | NA | |
6 | hsa-miR-181b-5p | ABCA5 | 1.11 | 0.02734 | 0.37 | 0.51209 | mirMAP | -0.19 | 0.00348 | NA | |
7 | hsa-miR-183-5p | ABCA8 | 6.62 | 0 | -8.05 | 0 | MirTarget | -0.32 | 0.00107 | NA | |
8 | hsa-let-7a-3p | ABCC9 | 0.83 | 0.04681 | -5.85 | 0 | mirMAP | -0.47 | 0.00079 | NA | |
9 | hsa-let-7f-1-3p | ABCC9 | 1.62 | 0.00069 | -5.85 | 0 | mirMAP | -0.66 | 0 | NA | |
10 | hsa-let-7a-3p | ABCD2 | 0.83 | 0.04681 | -2.82 | 0.00416 | mirMAP | -0.39 | 0.00433 | NA | |
11 | hsa-let-7f-1-3p | ABCD3 | 1.62 | 0.00069 | 0.36 | 0.31447 | MirTarget | -0.11 | 0.01345 | NA | |
12 | hsa-miR-181b-5p | ABI1 | 1.11 | 0.02734 | 0.65 | 0.07307 | MirTarget | -0.2 | 0 | NA | |
13 | hsa-miR-181d-5p | ABI1 | -0.53 | 0.32526 | 0.65 | 0.07307 | MirTarget | -0.17 | 1.0E-5 | NA | |
14 | hsa-miR-224-5p | ABI2 | 4.27 | 1.0E-5 | -1.23 | 0.00252 | mirMAP | -0.1 | 3.0E-5 | NA | |
15 | hsa-let-7a-3p | ABI3BP | 0.83 | 0.04681 | -5.04 | 2.0E-5 | miRNATAP | -0.55 | 0.00098 | NA | |
16 | hsa-miR-181b-5p | ABI3BP | 1.11 | 0.02734 | -5.04 | 2.0E-5 | miRNATAP | -0.29 | 0.03119 | NA | |
17 | hsa-let-7a-3p | ABLIM1 | 0.83 | 0.04681 | -0.15 | 0.81715 | mirMAP | -0.18 | 0.04197 | NA | |
18 | hsa-let-7f-1-3p | ABLIM1 | 1.62 | 0.00069 | -0.15 | 0.81715 | mirMAP | -0.16 | 0.04285 | NA | |
19 | hsa-miR-181b-5p | ACAP2 | 1.11 | 0.02734 | 0.49 | 0.26503 | MirTarget; miRNATAP | -0.16 | 0.00114 | NA | |
20 | hsa-miR-181b-5p | ACSL1 | 1.11 | 0.02734 | -0.26 | 0.66804 | MirTarget | -0.27 | 0.00011 | NA | |
21 | hsa-miR-181d-5p | ACSL1 | -0.53 | 0.32526 | -0.26 | 0.66804 | MirTarget | -0.14 | 0.03075 | NA | |
22 | hsa-miR-224-5p | ACSL4 | 4.27 | 1.0E-5 | -0.89 | 0.13062 | MirTarget | -0.11 | 0.00143 | NA | |
23 | hsa-miR-181b-5p | ACSS1 | 1.11 | 0.02734 | -0.48 | 0.54243 | mirMAP | -0.2 | 0.02708 | NA | |
24 | hsa-miR-15a-5p | ACSS2 | 2.05 | 0 | 0.06 | 0.8809 | MirTarget | -0.12 | 0.01889 | NA | |
25 | hsa-miR-224-5p | ACTR3B | 4.27 | 1.0E-5 | -0.49 | 0.29937 | MirTarget | -0.13 | 0 | NA | |
26 | hsa-miR-181b-5p | ACVR1C | 1.11 | 0.02734 | 1.69 | 0.1187 | miRNATAP | -0.31 | 0.01166 | NA | |
27 | hsa-let-7f-1-3p | ACVR2B | 1.62 | 0.00069 | -0.47 | 0.3473 | MirTarget | -0.2 | 0.00088 | NA | |
28 | hsa-miR-139-3p | ADAM11 | -2.55 | 0.00045 | -2.44 | 0.00581 | MirTarget | -0.14 | 0.04914 | NA | |
29 | hsa-miR-224-5p | ADAM22 | 4.27 | 1.0E-5 | -1.69 | 0.18073 | MirTarget | -0.21 | 0.00458 | NA | |
30 | hsa-let-7f-1-3p | ADAM23 | 1.62 | 0.00069 | -1.16 | 0.57179 | mirMAP | -0.54 | 0.02829 | NA | |
31 | hsa-miR-224-5p | ADAMTS2 | 4.27 | 1.0E-5 | -2.49 | 0.0191 | mirMAP | -0.13 | 0.0327 | NA | |
32 | hsa-miR-15a-5p | ADAMTS3 | 2.05 | 0 | -3.48 | 0.00158 | miRNATAP | -0.46 | 0.00134 | NA | |
33 | hsa-let-7a-3p | ADAMTS5 | 0.83 | 0.04681 | -6.22 | 0 | mirMAP | -0.41 | 0.00244 | NA | |
34 | hsa-let-7f-1-3p | ADAMTS5 | 1.62 | 0.00069 | -6.22 | 0 | mirMAP | -0.62 | 0 | NA | |
35 | hsa-miR-15a-5p | ADAMTS5 | 2.05 | 0 | -6.22 | 0 | miRNATAP | -0.54 | 2.0E-5 | NA | |
36 | hsa-let-7f-1-3p | ADAMTS9 | 1.62 | 0.00069 | -3.73 | 2.0E-5 | mirMAP | -0.49 | 0 | NA | |
37 | hsa-miR-181b-5p | ADAMTSL1 | 1.11 | 0.02734 | -5.88 | 0 | miRNATAP | -0.33 | 0.008 | NA | |
38 | hsa-miR-15a-5p | ADAMTSL3 | 2.05 | 0 | -3.54 | 0.01144 | MirTarget | -0.37 | 0.04793 | NA | |
39 | hsa-miR-224-5p | ADCYAP1 | 4.27 | 1.0E-5 | -5.14 | 0.00012 | mirMAP | -0.33 | 3.0E-5 | NA | |
40 | hsa-let-7a-3p | ADD3 | 0.83 | 0.04681 | 0.29 | 0.59978 | mirMAP; miRNATAP | -0.17 | 0.02915 | NA | |
41 | hsa-let-7f-1-3p | ADD3 | 1.62 | 0.00069 | 0.29 | 0.59978 | mirMAP | -0.15 | 0.02744 | NA | |
42 | hsa-miR-181d-5p | ADM | -0.53 | 0.32526 | 1.98 | 0.02456 | MirTarget | -0.19 | 0.04514 | NA | |
43 | hsa-let-7f-1-3p | AFF2 | 1.62 | 0.00069 | -0.5 | 0.77135 | mirMAP | -0.75 | 0.00027 | NA | |
44 | hsa-let-7a-3p | AFF3 | 0.83 | 0.04681 | -4.69 | 0 | MirTarget | -0.51 | 0.0001 | NA | |
45 | hsa-let-7f-1-3p | AFF3 | 1.62 | 0.00069 | -4.69 | 0 | MirTarget | -0.74 | 0 | NA | |
46 | hsa-miR-224-5p | AFF3 | 4.27 | 1.0E-5 | -4.69 | 0 | MirTarget | -0.27 | 0 | NA | |
47 | hsa-let-7a-3p | AFF4 | 0.83 | 0.04681 | -0.54 | 0.12416 | MirTarget; mirMAP | -0.14 | 0.0028 | NA | |
48 | hsa-let-7f-1-3p | AFF4 | 1.62 | 0.00069 | -0.54 | 0.12416 | MirTarget; mirMAP | -0.12 | 0.00488 | NA | |
49 | hsa-miR-181b-5p | AFTPH | 1.11 | 0.02734 | 0.31 | 0.22619 | MirTarget; miRNATAP | -0.11 | 9.0E-5 | NA | |
50 | hsa-miR-181b-5p | AGFG2 | 1.11 | 0.02734 | -1.25 | 0.00413 | mirMAP | -0.14 | 0.00331 | NA | |
51 | hsa-miR-183-5p | AJAP1 | 6.62 | 0 | -2.49 | 0.05813 | MirTarget | -0.24 | 0.00594 | NA | |
52 | hsa-let-7a-3p | AKAP11 | 0.83 | 0.04681 | -0.61 | 0.12508 | mirMAP | -0.25 | 0 | NA | |
53 | hsa-let-7f-1-3p | AKAP11 | 1.62 | 0.00069 | -0.61 | 0.12508 | mirMAP | -0.15 | 0.00129 | NA | |
54 | hsa-let-7a-3p | AKAP9 | 0.83 | 0.04681 | 0.02 | 0.95129 | MirTarget | -0.17 | 0.00078 | NA | |
55 | hsa-let-7f-1-3p | AKAP9 | 1.62 | 0.00069 | 0.02 | 0.95129 | MirTarget | -0.13 | 0.00367 | NA | |
56 | hsa-miR-181b-5p | AKR1C1 | 1.11 | 0.02734 | 0.79 | 0.6259 | mirMAP | -0.56 | 0.00205 | NA | |
57 | hsa-miR-15a-5p | AKT3 | 2.05 | 0 | -3.33 | 1.0E-5 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.37 | 0.00021 | NA | |
58 | hsa-let-7f-1-3p | ALDH5A1 | 1.62 | 0.00069 | 0.43 | 0.4556 | mirMAP | -0.22 | 0.00146 | NA | |
59 | hsa-let-7f-1-3p | ALDH7A1 | 1.62 | 0.00069 | -0.55 | 0.61727 | mirMAP | -0.27 | 0.04228 | NA | |
60 | hsa-let-7f-1-3p | AMN1 | 1.62 | 0.00069 | -1.15 | 0.01554 | mirMAP | -0.24 | 2.0E-5 | NA | |
61 | hsa-let-7a-3p | AMOT | 0.83 | 0.04681 | -1.94 | 0.20701 | mirMAP | -0.59 | 0.00568 | NA | |
62 | hsa-let-7f-1-3p | AMOT | 1.62 | 0.00069 | -1.94 | 0.20701 | mirMAP | -1.03 | 0 | NA | |
63 | hsa-miR-224-5p | AMZ1 | 4.27 | 1.0E-5 | -1.49 | 0.10286 | mirMAP | -0.13 | 0.0164 | NA | |
64 | hsa-miR-194-5p | ANGPTL1 | 0.69 | 0.52314 | -8.04 | 0 | MirTarget | -0.15 | 0.02902 | NA | |
65 | hsa-miR-15a-5p | ANK2 | 2.05 | 0 | -5.41 | 0 | MirTarget; miRNATAP | -0.62 | 2.0E-5 | NA | |
66 | hsa-let-7a-3p | ANK3 | 0.83 | 0.04681 | -0.05 | 0.94538 | MirTarget | -0.21 | 0.02601 | NA | |
67 | hsa-let-7f-1-3p | ANK3 | 1.62 | 0.00069 | -0.05 | 0.94538 | MirTarget | -0.28 | 0.0005 | NA | |
68 | hsa-miR-181b-5p | ANKMY1 | 1.11 | 0.02734 | -0.53 | 0.1888 | mirMAP | -0.19 | 3.0E-5 | NA | |
69 | hsa-miR-181b-5p | ANKRD12 | 1.11 | 0.02734 | -0.49 | 0.18892 | mirMAP | -0.16 | 0.00019 | NA | |
70 | hsa-miR-224-5p | ANKRD45 | 4.27 | 1.0E-5 | -2.8 | 0.03183 | MirTarget | -0.3 | 8.0E-5 | NA | |
71 | hsa-let-7a-3p | ANKS1B | 0.83 | 0.04681 | -3.57 | 0.00191 | miRNATAP | -0.42 | 0.00925 | NA | |
72 | hsa-miR-181b-5p | ANO1 | 1.11 | 0.02734 | 0.03 | 0.97495 | MirTarget; miRNATAP | -0.57 | 0 | NA | |
73 | hsa-let-7a-3p | ANO4 | 0.83 | 0.04681 | -4.46 | 0.00135 | MirTarget; miRNATAP | -0.62 | 0.00143 | NA | |
74 | hsa-let-7f-1-3p | ANO4 | 1.62 | 0.00069 | -4.46 | 0.00135 | MirTarget | -0.48 | 0.00412 | NA | |
75 | hsa-let-7a-3p | ANO5 | 0.83 | 0.04681 | -4.62 | 0.00063 | mirMAP | -0.71 | 0.00016 | NA | |
76 | hsa-let-7f-1-3p | ANO5 | 1.62 | 0.00069 | -4.62 | 0.00063 | mirMAP | -0.79 | 0 | NA | |
77 | hsa-miR-181b-5p | ANXA11 | 1.11 | 0.02734 | 0 | 0.98997 | MirTarget; mirMAP | -0.13 | 0.00299 | NA | |
78 | hsa-let-7a-3p | APC | 0.83 | 0.04681 | -0.08 | 0.84234 | mirMAP | -0.12 | 0.02517 | NA | |
79 | hsa-let-7f-1-3p | APC | 1.62 | 0.00069 | -0.08 | 0.84234 | mirMAP | -0.11 | 0.02128 | NA | |
80 | hsa-let-7a-3p | APPBP2 | 0.83 | 0.04681 | -0.69 | 0.0128 | mirMAP; miRNATAP | -0.12 | 0.00175 | NA | |
81 | hsa-let-7f-1-3p | APPL1 | 1.62 | 0.00069 | -0.45 | 0.2173 | MirTarget; mirMAP | -0.12 | 0.00459 | NA | |
82 | hsa-miR-15a-5p | AR | 2.05 | 0 | -4.57 | 0.00169 | mirMAP; miRNATAP | -0.77 | 5.0E-5 | NA | |
83 | hsa-miR-181b-5p | ARF6 | 1.11 | 0.02734 | 0.97 | 0.00132 | MirTarget | -0.14 | 3.0E-5 | NA | |
84 | hsa-miR-181d-5p | ARF6 | -0.53 | 0.32526 | 0.97 | 0.00132 | MirTarget | -0.14 | 1.0E-5 | NA | |
85 | hsa-let-7a-3p | ARFGEF2 | 0.83 | 0.04681 | 0.39 | 0.33431 | miRNATAP | -0.2 | 0.00024 | NA | |
86 | hsa-miR-181b-5p | ARFGEF2 | 1.11 | 0.02734 | 0.39 | 0.33431 | MirTarget; miRNATAP | -0.15 | 0.00063 | NA | |
87 | hsa-let-7a-3p | ARGLU1 | 0.83 | 0.04681 | 0.31 | 0.38739 | mirMAP | -0.14 | 0.00472 | NA | |
88 | hsa-let-7a-3p | ARHGAP12 | 0.83 | 0.04681 | -0.05 | 0.91839 | miRNATAP | -0.23 | 0.00019 | NA | |
89 | hsa-miR-181b-5p | ARHGAP19 | 1.11 | 0.02734 | -0.22 | 0.58517 | mirMAP | -0.14 | 0.00256 | NA | |
90 | hsa-let-7a-3p | ARHGAP20 | 0.83 | 0.04681 | -3.56 | 0.00051 | MirTarget; miRNATAP | -0.28 | 0.04657 | NA | |
91 | hsa-let-7f-1-3p | ARHGAP20 | 1.62 | 0.00069 | -3.56 | 0.00051 | MirTarget | -0.26 | 0.03518 | NA | |
92 | hsa-miR-15a-5p | ARHGAP20 | 2.05 | 0 | -3.56 | 0.00051 | MirTarget; miRNATAP | -0.63 | 0 | NA | |
93 | hsa-let-7f-1-3p | ARHGAP28 | 1.62 | 0.00069 | -2.52 | 0.04263 | mirMAP | -0.56 | 0.00017 | NA | |
94 | hsa-let-7a-3p | ARHGAP32 | 0.83 | 0.04681 | 0.91 | 0.12572 | mirMAP | -0.26 | 0.0016 | NA | |
95 | hsa-miR-181b-5p | ARHGAP32 | 1.11 | 0.02734 | 0.91 | 0.12572 | mirMAP | -0.27 | 4.0E-5 | NA | |
96 | hsa-miR-181b-5p | ARHGAP5 | 1.11 | 0.02734 | 0.28 | 0.45998 | mirMAP | -0.11 | 0.00714 | NA | |
97 | hsa-miR-183-5p | ARHGAP6 | 6.62 | 0 | -5.45 | 0 | MirTarget; miRNATAP | -0.15 | 0.01468 | NA | |
98 | hsa-miR-181b-5p | ARHGEF3 | 1.11 | 0.02734 | -1 | 0.016 | MirTarget | -0.11 | 0.01917 | NA | |
99 | hsa-miR-181d-5p | ARHGEF3 | -0.53 | 0.32526 | -1 | 0.016 | MirTarget | -0.14 | 0.00173 | NA | |
100 | hsa-miR-181b-5p | ARHGEF7 | 1.11 | 0.02734 | -0.35 | 0.21327 | MirTarget; miRNATAP | -0.11 | 0.00048 | NA | |
101 | hsa-let-7a-3p | ARID4A | 0.83 | 0.04681 | -0.65 | 0.04997 | MirTarget; miRNATAP | -0.17 | 0.00016 | NA | |
102 | hsa-let-7f-1-3p | ARID4A | 1.62 | 0.00069 | -0.65 | 0.04997 | MirTarget | -0.14 | 0.00034 | NA | |
103 | hsa-let-7a-3p | ARID5B | 0.83 | 0.04681 | -2.21 | 0 | miRNATAP | -0.13 | 0.03163 | NA | |
104 | hsa-let-7f-1-3p | ARL10 | 1.62 | 0.00069 | -0.75 | 0.35282 | mirMAP | -0.2 | 0.04331 | NA | |
105 | hsa-miR-15a-5p | ARL2 | 2.05 | 0 | -1.43 | 0.00052 | MirTarget; miRNATAP | -0.21 | 7.0E-5 | NA | |
106 | hsa-miR-15a-5p | ARMCX2 | 2.05 | 0 | -2.7 | 0.00294 | MirTarget; miRNATAP | -0.3 | 0.01228 | NA | |
107 | hsa-miR-224-5p | ARMCX2 | 4.27 | 1.0E-5 | -2.7 | 0.00294 | MirTarget | -0.21 | 6.0E-5 | NA | |
108 | hsa-miR-181b-5p | ARRDC4 | 1.11 | 0.02734 | -0.92 | 0.1366 | miRNATAP | -0.22 | 0.00128 | NA | |
109 | hsa-let-7a-3p | ARSB | 0.83 | 0.04681 | -0.81 | 0.05394 | mirMAP | -0.23 | 5.0E-5 | NA | |
110 | hsa-let-7f-1-3p | ARSB | 1.62 | 0.00069 | -0.81 | 0.05394 | mirMAP | -0.17 | 0.00085 | NA | |
111 | hsa-let-7a-3p | ASAH1 | 0.83 | 0.04681 | -0.58 | 0.14897 | MirTarget | -0.21 | 0.00013 | NA | |
112 | hsa-let-7f-1-3p | ASAH1 | 1.62 | 0.00069 | -0.58 | 0.14897 | MirTarget | -0.2 | 2.0E-5 | NA | |
113 | hsa-miR-194-5p | ASAP1 | 0.69 | 0.52314 | -0.15 | 0.71428 | MirTarget; miRNATAP | -0.13 | 0 | NA | |
114 | hsa-let-7a-3p | ASAP2 | 0.83 | 0.04681 | 0.25 | 0.58302 | MirTarget; miRNATAP | -0.16 | 0.01273 | NA | |
115 | hsa-miR-181b-5p | ASB13 | 1.11 | 0.02734 | -0.33 | 0.38533 | miRNAWalker2 validate | -0.16 | 0.00012 | NA | |
116 | hsa-miR-15a-5p | ASTN1 | 2.05 | 0 | -4.82 | 0.0004 | MirTarget | -0.82 | 0 | NA | |
117 | hsa-let-7f-1-3p | ASTN2 | 1.62 | 0.00069 | -1.99 | 0.06339 | mirMAP | -0.44 | 0.00059 | NA | |
118 | hsa-let-7a-3p | ASXL2 | 0.83 | 0.04681 | 0.95 | 0.22717 | mirMAP; miRNATAP | -0.34 | 0.00164 | NA | |
119 | hsa-let-7a-3p | ATE1 | 0.83 | 0.04681 | 0.43 | 0.49372 | mirMAP | -0.2 | 0.02098 | NA | |
120 | hsa-miR-181b-5p | ATE1 | 1.11 | 0.02734 | 0.43 | 0.49372 | mirMAP | -0.19 | 0.00584 | NA | |
121 | hsa-let-7a-3p | ATF2 | 0.83 | 0.04681 | 0.26 | 0.63833 | MirTarget; mirMAP; miRNATAP | -0.15 | 0.04116 | NA | |
122 | hsa-let-7a-3p | ATG2B | 0.83 | 0.04681 | -0.44 | 0.24501 | MirTarget | -0.15 | 0.00445 | NA | |
123 | hsa-let-7f-1-3p | ATG2B | 1.62 | 0.00069 | -0.44 | 0.24501 | MirTarget | -0.15 | 0.00055 | NA | |
124 | hsa-miR-183-5p | ATP10B | 6.62 | 0 | 3.53 | 0.02777 | MirTarget | -0.43 | 7.0E-5 | NA | |
125 | hsa-miR-181b-5p | ATP11B | 1.11 | 0.02734 | 0.87 | 0.09528 | MirTarget | -0.21 | 0.00026 | NA | |
126 | hsa-miR-181d-5p | ATP11B | -0.53 | 0.32526 | 0.87 | 0.09528 | MirTarget | -0.2 | 0.00032 | NA | |
127 | hsa-miR-224-5p | ATP8A1 | 4.27 | 1.0E-5 | -1.21 | 0.1241 | MirTarget | -0.2 | 2.0E-5 | NA | |
128 | hsa-miR-181b-5p | ATP8B1 | 1.11 | 0.02734 | 0.93 | 0.09129 | miRNATAP | -0.32 | 0 | NA | |
129 | hsa-miR-194-5p | ATP8B4 | 0.69 | 0.52314 | -2.31 | 0.00034 | MirTarget | -0.12 | 0.00043 | NA | |
130 | hsa-let-7a-3p | ATRX | 0.83 | 0.04681 | -0.47 | 0.18181 | MirTarget; miRNATAP | -0.13 | 0.00771 | NA | |
131 | hsa-let-7f-1-3p | ATRX | 1.62 | 0.00069 | -0.47 | 0.18181 | MirTarget | -0.16 | 0.00018 | NA | |
132 | hsa-miR-181b-5p | ATXN7 | 1.11 | 0.02734 | 0.19 | 0.62797 | MirTarget | -0.11 | 0.01048 | NA | |
133 | hsa-miR-15a-5p | ATXN7L1 | 2.05 | 0 | -0.2 | 0.58676 | miRNATAP | -0.11 | 0.02655 | NA | |
134 | hsa-miR-15a-5p | ATXN7L3B | 2.05 | 0 | -0.63 | 0.07776 | MirTarget | -0.15 | 0.00095 | NA | |
135 | hsa-let-7a-3p | AXIN2 | 0.83 | 0.04681 | -3.82 | 0.00033 | miRNATAP | -0.49 | 0.00085 | NA | |
136 | hsa-miR-15a-5p | AXIN2 | 2.05 | 0 | -3.82 | 0.00033 | MirTarget; miRNATAP | -0.55 | 8.0E-5 | 26252081 | The combination of miR-15a and AXIN2 significantly improved the diagnostic accuracy |
137 | hsa-miR-181b-5p | B3GALT5 | 1.11 | 0.02734 | 0.39 | 0.83072 | MirTarget | -0.64 | 0.00217 | NA | |
138 | hsa-miR-181b-5p | B3GNT5 | 1.11 | 0.02734 | 2.46 | 0.00043 | MirTarget | -0.2 | 0.01035 | NA | |
139 | hsa-miR-181d-5p | B3GNT5 | -0.53 | 0.32526 | 2.46 | 0.00043 | MirTarget | -0.28 | 0.00014 | NA | |
140 | hsa-miR-181b-5p | B4GALT4 | 1.11 | 0.02734 | 0.59 | 0.30576 | mirMAP | -0.14 | 0.03298 | NA | |
141 | hsa-miR-15a-5p | BACE1 | 2.05 | 0 | -1.41 | 0.00094 | miRNAWalker2 validate; miRNATAP | -0.18 | 0.00108 | NA | |
142 | hsa-miR-15a-5p | BACH2 | 2.05 | 0 | -2.73 | 0.00174 | MirTarget; miRNATAP | -0.3 | 0.01008 | NA | |
143 | hsa-let-7a-3p | BCAS1 | 0.83 | 0.04681 | -0.07 | 0.96835 | mirMAP | -0.89 | 0.00012 | NA | |
144 | hsa-let-7f-1-3p | BCAS1 | 1.62 | 0.00069 | -0.07 | 0.96835 | mirMAP | -0.84 | 2.0E-5 | NA | |
145 | hsa-miR-183-5p | BCL11B | 6.62 | 0 | 2.87 | 0.00737 | miRNAWalker2 validate; miRNATAP | -0.2 | 0.00496 | NA | |
146 | hsa-miR-181b-5p | BCL6 | 1.11 | 0.02734 | -0.53 | 0.26262 | miRNATAP | -0.21 | 7.0E-5 | NA | |
147 | hsa-miR-181b-5p | BCL6B | 1.11 | 0.02734 | -3.36 | 0 | MirTarget | -0.19 | 0.01291 | NA | |
148 | hsa-miR-181d-5p | BCL6B | -0.53 | 0.32526 | -3.36 | 0 | MirTarget | -0.22 | 0.00155 | NA | |
149 | hsa-let-7a-3p | BDP1 | 0.83 | 0.04681 | 0.05 | 0.90095 | MirTarget; mirMAP | -0.16 | 0.00465 | NA | |
150 | hsa-let-7f-1-3p | BDP1 | 1.62 | 0.00069 | 0.05 | 0.90095 | MirTarget; mirMAP | -0.13 | 0.00598 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | PROTEIN PHOSPHORYLATION | 118 | 944 | 1.228e-16 | 5.716e-13 |
2 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 174 | 1672 | 4.441e-16 | 9.565e-13 |
3 | NEUROGENESIS | 153 | 1402 | 6.167e-16 | 9.565e-13 |
4 | TISSUE DEVELOPMENT | 161 | 1518 | 1.262e-15 | 1.468e-12 |
5 | CELL DEVELOPMENT | 152 | 1426 | 5.91e-15 | 5.5e-12 |
6 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 118 | 1008 | 1.523e-14 | 1.181e-11 |
7 | PHOSPHORYLATION | 135 | 1228 | 2.294e-14 | 1.525e-11 |
8 | RESPONSE TO ENDOGENOUS STIMULUS | 149 | 1450 | 2.271e-13 | 1.288e-10 |
9 | REGULATION OF GTPASE ACTIVITY | 87 | 673 | 2.491e-13 | 1.288e-10 |
10 | REGULATION OF CELL DIFFERENTIATION | 151 | 1492 | 5.191e-13 | 2.013e-10 |
11 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 96 | 788 | 5.039e-13 | 2.013e-10 |
12 | CIRCULATORY SYSTEM DEVELOPMENT | 96 | 788 | 5.039e-13 | 2.013e-10 |
13 | ORGAN MORPHOGENESIS | 100 | 841 | 7.106e-13 | 2.543e-10 |
14 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 87 | 689 | 9.32e-13 | 3.098e-10 |
15 | EPITHELIUM DEVELOPMENT | 108 | 945 | 1.035e-12 | 3.21e-10 |
16 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 113 | 1021 | 2.428e-12 | 7.061e-10 |
17 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 129 | 1275 | 3.293e-11 | 9.013e-09 |
18 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 166 | 1791 | 4.515e-11 | 1.167e-08 |
19 | INTRACELLULAR SIGNAL TRANSDUCTION | 150 | 1572 | 5.621e-11 | 1.357e-08 |
20 | PEPTIDYL TYROSINE MODIFICATION | 36 | 186 | 5.834e-11 | 1.357e-08 |
21 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 118 | 1142 | 6.737e-11 | 1.493e-08 |
22 | NEURON DIFFERENTIATION | 97 | 874 | 8.38e-11 | 1.772e-08 |
23 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 87 | 750 | 8.87e-11 | 1.794e-08 |
24 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 96 | 872 | 1.64e-10 | 3.18e-08 |
25 | POSITIVE REGULATION OF GENE EXPRESSION | 159 | 1733 | 2.669e-10 | 4.967e-08 |
26 | TUBE DEVELOPMENT | 69 | 552 | 3.583e-10 | 6.263e-08 |
27 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 87 | 771 | 3.634e-10 | 6.263e-08 |
28 | REGULATION OF CELL DEVELOPMENT | 92 | 836 | 4.126e-10 | 6.856e-08 |
29 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 166 | 1848 | 5.032e-10 | 7.805e-08 |
30 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 175 | 1977 | 4.902e-10 | 7.805e-08 |
31 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 107 | 1036 | 5.793e-10 | 8.423e-08 |
32 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 107 | 1036 | 5.793e-10 | 8.423e-08 |
33 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 152 | 1656 | 6.857e-10 | 9.389e-08 |
34 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 161 | 1784 | 6.861e-10 | 9.389e-08 |
35 | REGULATION OF TRANSPORT | 162 | 1804 | 8.654e-10 | 1.15e-07 |
36 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 100 | 957 | 1.186e-09 | 1.533e-07 |
37 | UROGENITAL SYSTEM DEVELOPMENT | 45 | 299 | 1.503e-09 | 1.89e-07 |
38 | CELLULAR COMPONENT MORPHOGENESIS | 95 | 900 | 1.887e-09 | 2.311e-07 |
39 | BIOLOGICAL ADHESION | 105 | 1032 | 1.948e-09 | 2.324e-07 |
40 | LOCOMOTION | 111 | 1114 | 2.139e-09 | 2.489e-07 |
41 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 147 | 1618 | 2.736e-09 | 3.105e-07 |
42 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 160 | 1805 | 2.835e-09 | 3.141e-07 |
43 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 139 | 1518 | 4.782e-09 | 5.175e-07 |
44 | VASCULATURE DEVELOPMENT | 59 | 469 | 5.467e-09 | 5.781e-07 |
45 | TUBE MORPHOGENESIS | 46 | 323 | 5.959e-09 | 6.162e-07 |
46 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 101 | 1004 | 7.328e-09 | 7.412e-07 |
47 | TISSUE MORPHOGENESIS | 64 | 533 | 7.807e-09 | 7.729e-07 |
48 | PROTEIN AUTOPHOSPHORYLATION | 33 | 192 | 8.496e-09 | 8.235e-07 |
49 | POSITIVE REGULATION OF HYDROLASE ACTIVITY | 93 | 905 | 1.07e-08 | 1.015e-06 |
50 | HEART DEVELOPMENT | 58 | 466 | 1.09e-08 | 1.015e-06 |
51 | BLOOD VESSEL MORPHOGENESIS | 49 | 364 | 1.248e-08 | 1.139e-06 |
52 | CELLULAR RESPONSE TO HORMONE STIMULUS | 65 | 552 | 1.283e-08 | 1.148e-06 |
53 | REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 41 | 278 | 1.452e-08 | 1.274e-06 |
54 | CELL MOTILITY | 87 | 835 | 1.729e-08 | 1.463e-06 |
55 | LOCALIZATION OF CELL | 87 | 835 | 1.729e-08 | 1.463e-06 |
56 | NEURON PROJECTION DEVELOPMENT | 64 | 545 | 1.848e-08 | 1.518e-06 |
57 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 128 | 1395 | 1.86e-08 | 1.518e-06 |
58 | REGULATION OF CELL PROJECTION ORGANIZATION | 65 | 558 | 1.952e-08 | 1.566e-06 |
59 | REGULATION OF CELL PROLIFERATION | 134 | 1496 | 3.567e-08 | 2.813e-06 |
60 | REGULATION OF HYDROLASE ACTIVITY | 122 | 1327 | 3.724e-08 | 2.888e-06 |
61 | MORPHOGENESIS OF AN EPITHELIUM | 51 | 400 | 3.855e-08 | 2.94e-06 |
62 | HEAD DEVELOPMENT | 76 | 709 | 4.451e-08 | 3.34e-06 |
63 | RESPONSE TO HORMONE | 90 | 893 | 4.645e-08 | 3.431e-06 |
64 | EMBRYO DEVELOPMENT | 90 | 894 | 4.892e-08 | 3.502e-06 |
65 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 59 | 498 | 4.886e-08 | 3.502e-06 |
66 | RESPONSE TO GROWTH FACTOR | 57 | 475 | 5.301e-08 | 3.737e-06 |
67 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 60 | 513 | 5.972e-08 | 4.148e-06 |
68 | CELL PROJECTION ORGANIZATION | 90 | 902 | 7.367e-08 | 5.041e-06 |
69 | REGULATION OF PROTEIN MODIFICATION PROCESS | 147 | 1710 | 9.591e-08 | 6.468e-06 |
70 | NEURON DEVELOPMENT | 73 | 687 | 1.172e-07 | 7.792e-06 |
71 | ACTIN FILAMENT BASED PROCESS | 54 | 450 | 1.189e-07 | 7.793e-06 |
72 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 83 | 823 | 1.539e-07 | 9.946e-06 |
73 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 81 | 799 | 1.757e-07 | 1.115e-05 |
74 | REGULATION OF NEURON DIFFERENTIATION | 62 | 554 | 1.774e-07 | 1.115e-05 |
75 | REGULATION OF SYSTEM PROCESS | 58 | 507 | 2.119e-07 | 1.315e-05 |
76 | POSITIVE REGULATION OF CELL COMMUNICATION | 133 | 1532 | 2.451e-07 | 1.5e-05 |
77 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 105 | 1135 | 2.66e-07 | 1.607e-05 |
78 | NEGATIVE REGULATION OF CELL COMMUNICATION | 109 | 1192 | 2.765e-07 | 1.65e-05 |
79 | EMBRYONIC MORPHOGENESIS | 60 | 539 | 3.365e-07 | 1.982e-05 |
80 | MODULATION OF SYNAPTIC TRANSMISSION | 40 | 301 | 3.795e-07 | 2.208e-05 |
81 | METANEPHROS DEVELOPMENT | 18 | 81 | 4.275e-07 | 2.447e-05 |
82 | KIDNEY EPITHELIUM DEVELOPMENT | 23 | 125 | 4.313e-07 | 2.447e-05 |
83 | SINGLE ORGANISM BEHAVIOR | 47 | 384 | 4.405e-07 | 2.47e-05 |
84 | CELL PROLIFERATION | 70 | 672 | 4.531e-07 | 2.51e-05 |
85 | REGULATION OF MAPK CASCADE | 69 | 660 | 4.795e-07 | 2.625e-05 |
86 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 51 | 437 | 6.268e-07 | 3.391e-05 |
87 | CYTOSKELETON ORGANIZATION | 82 | 838 | 6.386e-07 | 3.415e-05 |
88 | REGULATION OF CELL DEATH | 127 | 1472 | 6.57e-07 | 3.474e-05 |
89 | MORPHOGENESIS OF A BRANCHING STRUCTURE | 27 | 167 | 6.688e-07 | 3.497e-05 |
90 | CELL JUNCTION ASSEMBLY | 23 | 129 | 7.707e-07 | 3.985e-05 |
91 | BEHAVIOR | 57 | 516 | 8.482e-07 | 4.337e-05 |
92 | POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 14 | 53 | 8.835e-07 | 4.451e-05 |
93 | REGULATION OF PHOSPHOLIPASE C ACTIVITY | 12 | 39 | 8.896e-07 | 4.451e-05 |
94 | SENSORY ORGAN DEVELOPMENT | 55 | 493 | 9.689e-07 | 4.796e-05 |
95 | POSITIVE REGULATION OF CELL DEVELOPMENT | 53 | 472 | 1.251e-06 | 6.127e-05 |
96 | POSITIVE REGULATION OF CELL PROLIFERATION | 79 | 814 | 1.417e-06 | 6.867e-05 |
97 | REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 28 | 184 | 1.465e-06 | 6.954e-05 |
98 | INOSITOL LIPID MEDIATED SIGNALING | 22 | 124 | 1.452e-06 | 6.954e-05 |
99 | METANEPHROS MORPHOGENESIS | 10 | 28 | 1.563e-06 | 7.347e-05 |
100 | REGULATION OF MEMBRANE POTENTIAL | 42 | 343 | 1.769e-06 | 8.229e-05 |
101 | REGULATION OF PHOSPHOLIPASE ACTIVITY | 15 | 64 | 1.9e-06 | 8.754e-05 |
102 | REGULATION OF EPITHELIAL CELL MIGRATION | 26 | 166 | 1.983e-06 | 9.045e-05 |
103 | REGULATION OF TRANSPORTER ACTIVITY | 29 | 198 | 2.12e-06 | 9.576e-05 |
104 | MUSCLE STRUCTURE DEVELOPMENT | 49 | 432 | 2.356e-06 | 0.0001054 |
105 | EPITHELIAL CELL DIFFERENTIATION | 54 | 495 | 2.404e-06 | 0.0001065 |
106 | INTRACELLULAR RECEPTOR SIGNALING PATHWAY | 26 | 168 | 2.494e-06 | 0.0001085 |
107 | KIDNEY MORPHOGENESIS | 17 | 82 | 2.486e-06 | 0.0001085 |
108 | REGULATION OF VASCULATURE DEVELOPMENT | 32 | 233 | 2.673e-06 | 0.0001152 |
109 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 38 | 303 | 3.069e-06 | 0.000131 |
110 | NEGATIVE REGULATION OF CELL PROLIFERATION | 65 | 643 | 3.244e-06 | 0.0001372 |
111 | ACTIN FILAMENT BASED MOVEMENT | 18 | 93 | 3.594e-06 | 0.0001492 |
112 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 125 | 1492 | 3.612e-06 | 0.0001492 |
113 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 116 | 1360 | 3.623e-06 | 0.0001492 |
114 | NEGATIVE REGULATION OF GENE EXPRESSION | 125 | 1493 | 3.734e-06 | 0.0001524 |
115 | REGULATION OF CELLULAR COMPONENT BIOGENESIS | 74 | 767 | 3.798e-06 | 0.0001537 |
116 | SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION | 46 | 404 | 4.305e-06 | 0.0001727 |
117 | MULTICELLULAR ORGANISMAL SIGNALING | 21 | 123 | 4.714e-06 | 0.0001875 |
118 | PEPTIDYL AMINO ACID MODIFICATION | 79 | 841 | 4.875e-06 | 0.0001922 |
119 | FOREBRAIN DEVELOPMENT | 42 | 357 | 4.932e-06 | 0.0001929 |
120 | POSITIVE REGULATION OF KINASE ACTIVITY | 52 | 482 | 5.079e-06 | 0.0001969 |
121 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 76 | 801 | 5.163e-06 | 0.0001985 |
122 | REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 51 | 470 | 5.305e-06 | 0.0002023 |
123 | GLAND DEVELOPMENT | 45 | 395 | 5.379e-06 | 0.0002035 |
124 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 46 | 408 | 5.598e-06 | 0.00021 |
125 | RENAL TUBULE DEVELOPMENT | 16 | 78 | 5.647e-06 | 0.0002102 |
126 | REGULATION OF KINASE ACTIVITY | 74 | 776 | 5.757e-06 | 0.0002126 |
127 | NEPHRON DEVELOPMENT | 20 | 115 | 5.907e-06 | 0.0002164 |
128 | STEROID HORMONE MEDIATED SIGNALING PATHWAY | 21 | 125 | 6.128e-06 | 0.0002228 |
129 | NEURAL PRECURSOR CELL PROLIFERATION | 15 | 70 | 6.259e-06 | 0.0002258 |
130 | REGULATION OF PEPTIDE SECRETION | 29 | 209 | 6.32e-06 | 0.0002262 |
131 | GROWTH | 46 | 410 | 6.371e-06 | 0.0002263 |
132 | EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 57 | 554 | 7.708e-06 | 0.0002717 |
133 | HORMONE MEDIATED SIGNALING PATHWAY | 24 | 158 | 8.329e-06 | 0.0002914 |
134 | LIPID PHOSPHORYLATION | 18 | 99 | 9.016e-06 | 0.0003131 |
135 | SKELETAL SYSTEM DEVELOPMENT | 49 | 455 | 9.918e-06 | 0.0003419 |
136 | METANEPHRIC NEPHRON MORPHOGENESIS | 8 | 21 | 1.023e-05 | 0.0003475 |
137 | PLASMA MEMBRANE ORGANIZATION | 28 | 203 | 1.017e-05 | 0.0003475 |
138 | EMBRYONIC ORGAN DEVELOPMENT | 45 | 406 | 1.095e-05 | 0.0003692 |
139 | CELLULAR RESPONSE TO LIPID | 49 | 457 | 1.116e-05 | 0.0003737 |
140 | POSITIVE REGULATION OF MAPK CASCADE | 50 | 470 | 1.128e-05 | 0.000375 |
141 | NEGATIVE REGULATION OF TRANSPORT | 49 | 458 | 1.184e-05 | 0.0003879 |
142 | DEVELOPMENTAL GROWTH | 39 | 333 | 1.182e-05 | 0.0003879 |
143 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 115 | 1381 | 1.203e-05 | 0.0003914 |
144 | REGULATION OF HORMONE SECRETION | 33 | 262 | 1.227e-05 | 0.0003964 |
145 | RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 7 | 16 | 1.27e-05 | 0.0004074 |
146 | RHYTHMIC PROCESS | 36 | 298 | 1.284e-05 | 0.0004094 |
147 | BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 21 | 131 | 1.297e-05 | 0.0004105 |
148 | MUSCLE TISSUE DEVELOPMENT | 34 | 275 | 1.357e-05 | 0.0004267 |
149 | REGULATION OF PROTEIN LOCALIZATION | 85 | 950 | 1.379e-05 | 0.0004307 |
150 | REGULATION OF ION TRANSPORT | 59 | 592 | 1.409e-05 | 0.000437 |
151 | POSITIVE REGULATION OF LIPASE ACTIVITY | 14 | 66 | 1.435e-05 | 0.0004422 |
152 | NEPHRON EPITHELIUM DEVELOPMENT | 17 | 93 | 1.476e-05 | 0.0004517 |
153 | CELL JUNCTION ORGANIZATION | 26 | 185 | 1.489e-05 | 0.000453 |
154 | POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 18 | 103 | 1.591e-05 | 0.0004808 |
155 | RESPIRATORY SYSTEM DEVELOPMENT | 27 | 197 | 1.636e-05 | 0.000491 |
156 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 60 | 609 | 1.687e-05 | 0.0005033 |
157 | VASCULOGENESIS | 13 | 59 | 1.874e-05 | 0.0005555 |
158 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 82 | 917 | 2.001e-05 | 0.0005894 |
159 | ODONTOGENESIS | 18 | 105 | 2.088e-05 | 0.0006112 |
160 | ANGIOGENESIS | 35 | 293 | 2.146e-05 | 0.0006241 |
161 | REGULATION OF OSSIFICATION | 25 | 178 | 2.183e-05 | 0.0006309 |
162 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 36 | 306 | 2.294e-05 | 0.0006558 |
163 | REGULATION OF CELL CYCLE | 84 | 949 | 2.297e-05 | 0.0006558 |
164 | REGULATION OF CELL ADHESION | 61 | 629 | 2.312e-05 | 0.0006559 |
165 | REGULATION OF CELL MORPHOGENESIS | 55 | 552 | 2.755e-05 | 0.0007768 |
166 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 34 | 285 | 2.875e-05 | 0.0008037 |
167 | NEGATIVE REGULATION OF PHOSPHORYLATION | 45 | 422 | 2.884e-05 | 0.0008037 |
168 | REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 21 | 138 | 2.914e-05 | 0.000807 |
169 | NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS | 122 | 1517 | 3.194e-05 | 0.0008794 |
170 | RESPONSE TO OXYGEN LEVELS | 36 | 311 | 3.25e-05 | 0.0008895 |
171 | COGNITION | 31 | 251 | 3.273e-05 | 0.0008906 |
172 | CONNECTIVE TISSUE DEVELOPMENT | 26 | 194 | 3.451e-05 | 0.0009336 |
173 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 48 | 465 | 3.648e-05 | 0.0009756 |
174 | ENDOMEMBRANE SYSTEM ORGANIZATION | 48 | 465 | 3.648e-05 | 0.0009756 |
175 | MESONEPHROS DEVELOPMENT | 16 | 90 | 3.736e-05 | 0.0009934 |
176 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 51 | 505 | 3.762e-05 | 0.0009945 |
177 | CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 28 | 218 | 3.837e-05 | 0.001009 |
178 | REGULATION OF CELL SUBSTRATE ADHESION | 24 | 173 | 3.88e-05 | 0.001014 |
179 | WNT SIGNALING PATHWAY | 39 | 351 | 3.922e-05 | 0.00102 |
180 | NEURON PROJECTION MORPHOGENESIS | 43 | 402 | 4.006e-05 | 0.00103 |
181 | NEURON MIGRATION | 18 | 110 | 3.985e-05 | 0.00103 |
182 | REGULATION OF ORGAN MORPHOGENESIS | 30 | 242 | 4.062e-05 | 0.001039 |
183 | SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 39 | 352 | 4.178e-05 | 0.001062 |
184 | EPITHELIAL CELL DEVELOPMENT | 25 | 186 | 4.617e-05 | 0.001167 |
185 | METANEPHRIC NEPHRON DEVELOPMENT | 9 | 32 | 4.688e-05 | 0.001179 |
186 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 85 | 983 | 4.75e-05 | 0.001182 |
187 | REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 14 | 73 | 4.746e-05 | 0.001182 |
188 | REGULATION OF PEPTIDE TRANSPORT | 31 | 256 | 4.79e-05 | 0.001185 |
189 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 148 | 1929 | 4.83e-05 | 0.001189 |
190 | REGULATION OF CELLULAR LOCALIZATION | 105 | 1277 | 4.911e-05 | 0.001203 |
191 | REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 19 | 122 | 4.977e-05 | 0.001212 |
192 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 40 | 368 | 5.151e-05 | 0.001248 |
193 | CELL PART MORPHOGENESIS | 60 | 633 | 5.216e-05 | 0.001256 |
194 | REGULATION OF DENDRITIC SPINE DEVELOPMENT | 12 | 56 | 5.237e-05 | 0.001256 |
195 | POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 20 | 133 | 5.32e-05 | 0.001263 |
196 | REGULATION OF LIPASE ACTIVITY | 15 | 83 | 5.319e-05 | 0.001263 |
197 | POSITIVE REGULATION OF LOCOMOTION | 44 | 420 | 5.376e-05 | 0.00127 |
198 | REGULATION OF MAP KINASE ACTIVITY | 36 | 319 | 5.554e-05 | 0.001305 |
199 | MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 6 | 14 | 6.317e-05 | 0.001477 |
200 | TAXIS | 47 | 464 | 6.967e-05 | 0.001621 |
201 | CELLULAR RESPONSE TO ALCOHOL | 18 | 115 | 7.279e-05 | 0.001685 |
202 | CELLULAR RESPONSE TO PEPTIDE | 32 | 274 | 7.366e-05 | 0.001697 |
203 | POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 58 | 616 | 8.315e-05 | 0.001906 |
204 | LIPID LOCALIZATION | 31 | 264 | 8.57e-05 | 0.001945 |
205 | TELENCEPHALON DEVELOPMENT | 28 | 228 | 8.54e-05 | 0.001945 |
206 | EYE DEVELOPMENT | 36 | 326 | 8.693e-05 | 0.001964 |
207 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 28 | 229 | 9.22e-05 | 0.002072 |
208 | REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 18 | 118 | 0.0001025 | 0.002293 |
209 | EMBRYONIC ORGAN MORPHOGENESIS | 32 | 279 | 0.0001039 | 0.002313 |
210 | PROTEIN LOCALIZATION | 138 | 1805 | 0.0001048 | 0.002322 |
211 | EXTRACELLULAR STRUCTURE ORGANIZATION | 34 | 304 | 0.0001054 | 0.002325 |
212 | REGULATION OF STEM CELL PROLIFERATION | 15 | 88 | 0.0001067 | 0.002341 |
213 | REGULATION OF NEUROBLAST PROLIFERATION | 8 | 28 | 0.0001099 | 0.0024 |
214 | DENDRITE DEVELOPMENT | 14 | 79 | 0.0001166 | 0.002536 |
215 | EPITHELIAL CELL PROLIFERATION | 15 | 89 | 0.0001217 | 0.002622 |
216 | POST EMBRYONIC DEVELOPMENT | 15 | 89 | 0.0001217 | 0.002622 |
217 | LIPID METABOLIC PROCESS | 95 | 1158 | 0.000123 | 0.002627 |
218 | REGULATION OF CYTOSKELETON ORGANIZATION | 49 | 502 | 0.0001231 | 0.002627 |
219 | REGULATION OF NUCLEOTIDE CATABOLIC PROCESS | 9 | 36 | 0.0001284 | 0.002728 |
220 | LIPID MODIFICATION | 26 | 210 | 0.0001318 | 0.002776 |
221 | REGULATION OF BLOOD CIRCULATION | 33 | 295 | 0.0001319 | 0.002776 |
222 | REGULATION OF BINDING | 32 | 283 | 0.0001356 | 0.002843 |
223 | REGULATION OF CELL MATRIX ADHESION | 15 | 90 | 0.0001386 | 0.002892 |
224 | REGULATION OF HORMONE LEVELS | 47 | 478 | 0.0001416 | 0.002941 |
225 | REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 11 | 53 | 0.0001448 | 0.002956 |
226 | MAMMARY GLAND EPITHELIUM DEVELOPMENT | 11 | 53 | 0.0001448 | 0.002956 |
227 | CARDIAC MUSCLE CELL CONTRACTION | 8 | 29 | 0.0001443 | 0.002956 |
228 | REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 8 | 29 | 0.0001443 | 0.002956 |
229 | CELL CYCLE ARREST | 21 | 154 | 0.0001479 | 0.002994 |
230 | SECRETION | 55 | 588 | 0.0001493 | 0.002994 |
231 | RAS PROTEIN SIGNAL TRANSDUCTION | 20 | 143 | 0.0001487 | 0.002994 |
232 | POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 12 | 62 | 0.0001484 | 0.002994 |
233 | MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION | 6 | 16 | 0.0001528 | 0.003039 |
234 | POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT5 PROTEIN | 6 | 16 | 0.0001528 | 0.003039 |
235 | NEGATIVE REGULATION OF CELL DEATH | 75 | 872 | 0.0001559 | 0.003087 |
236 | REGULATION OF TRANSFERASE ACTIVITY | 80 | 946 | 0.0001636 | 0.0032 |
237 | RESPONSE TO ALCOHOL | 38 | 362 | 0.0001625 | 0.0032 |
238 | SKELETAL SYSTEM MORPHOGENESIS | 25 | 201 | 0.0001637 | 0.0032 |
239 | NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 30 | 262 | 0.0001736 | 0.003335 |
240 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 34 | 312 | 0.0001742 | 0.003335 |
241 | MESENCHYME DEVELOPMENT | 24 | 190 | 0.000173 | 0.003335 |
242 | STEM CELL DIFFERENTIATION | 24 | 190 | 0.000173 | 0.003335 |
243 | TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 24 | 190 | 0.000173 | 0.003335 |
244 | CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 8 | 30 | 0.0001871 | 0.003569 |
245 | ADRENAL GLAND DEVELOPMENT | 7 | 23 | 0.0001922 | 0.003651 |
246 | REGULATION OF DEVELOPMENTAL GROWTH | 32 | 289 | 0.0001997 | 0.003777 |
247 | COLLAGEN FIBRIL ORGANIZATION | 9 | 38 | 0.0002009 | 0.003785 |
248 | REGULATION OF DNA BINDING | 15 | 93 | 0.000202 | 0.003789 |
249 | CIRCULATORY SYSTEM PROCESS | 38 | 366 | 0.0002032 | 0.003798 |
250 | REGULATION OF KIDNEY DEVELOPMENT | 11 | 55 | 0.0002051 | 0.003818 |
251 | MUSCLE ORGAN DEVELOPMENT | 31 | 277 | 0.0002063 | 0.003824 |
252 | CARTILAGE DEVELOPMENT | 20 | 147 | 0.0002172 | 0.004011 |
253 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 64 | 724 | 0.0002229 | 0.004057 |
254 | REGULATION OF HOMEOSTATIC PROCESS | 44 | 447 | 0.0002226 | 0.004057 |
255 | POSITIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS | 6 | 17 | 0.000225 | 0.004057 |
256 | ACTIN MEDIATED CELL CONTRACTION | 13 | 74 | 0.0002216 | 0.004057 |
257 | MAMMARY GLAND ALVEOLUS DEVELOPMENT | 6 | 17 | 0.000225 | 0.004057 |
258 | MAMMARY GLAND LOBULE DEVELOPMENT | 6 | 17 | 0.000225 | 0.004057 |
259 | ACTION POTENTIAL | 15 | 94 | 0.000228 | 0.004096 |
260 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 65 | 740 | 0.0002381 | 0.004261 |
261 | NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 18 | 126 | 0.0002394 | 0.004267 |
262 | POSITIVE REGULATION OF AUTOPHAGY | 13 | 75 | 0.0002545 | 0.00452 |
263 | EAR DEVELOPMENT | 24 | 195 | 0.0002572 | 0.00455 |
264 | NEURAL TUBE DEVELOPMENT | 20 | 149 | 0.0002608 | 0.004597 |
265 | MAMMARY GLAND DEVELOPMENT | 17 | 117 | 0.0002875 | 0.005047 |
266 | POSITIVE REGULATION OF TRANSPORTER ACTIVITY | 13 | 76 | 0.0002915 | 0.005099 |
267 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 74 | 876 | 0.0002953 | 0.005141 |
268 | REGULATION OF TRANSMEMBRANE TRANSPORT | 42 | 426 | 0.0002961 | 0.005141 |
269 | RESPONSE TO WOUNDING | 52 | 563 | 0.0003037 | 0.005237 |
270 | NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 9 | 40 | 0.0003045 | 0.005237 |
271 | REGULATION OF GROWTH | 57 | 633 | 0.000305 | 0.005237 |
272 | PROTEIN LOCALIZATION TO CELL PERIPHERY | 20 | 151 | 0.000312 | 0.005336 |
273 | CARDIAC MUSCLE TISSUE DEVELOPMENT | 19 | 140 | 0.0003192 | 0.00544 |
274 | SMOOTH MUSCLE TISSUE DEVELOPMENT | 6 | 18 | 0.0003215 | 0.005459 |
275 | PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 10 | 49 | 0.0003332 | 0.005638 |
276 | CELLULAR RESPONSE TO ACID CHEMICAL | 22 | 175 | 0.000339 | 0.005715 |
277 | EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS | 7 | 25 | 0.0003414 | 0.005715 |
278 | REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 7 | 25 | 0.0003414 | 0.005715 |
279 | REGIONALIZATION | 33 | 311 | 0.0003508 | 0.005851 |
280 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 35 | 337 | 0.0003538 | 0.005879 |
281 | ORGAN GROWTH | 12 | 68 | 0.0003667 | 0.006073 |
282 | TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER | 20 | 153 | 0.0003716 | 0.006131 |
283 | IMMUNE SYSTEM DEVELOPMENT | 53 | 582 | 0.0003752 | 0.006169 |
284 | EMBRYONIC EYE MORPHOGENESIS | 8 | 33 | 0.000382 | 0.006258 |
285 | PATTERN SPECIFICATION PROCESS | 41 | 418 | 0.0003862 | 0.006305 |
286 | MUSCLE CELL DIFFERENTIATION | 27 | 237 | 0.0003887 | 0.006323 |
287 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 92 | 1152 | 0.0003914 | 0.006345 |
288 | REGULATION OF ADHERENS JUNCTION ORGANIZATION | 10 | 50 | 0.0003958 | 0.006394 |
289 | POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 20 | 154 | 0.000405 | 0.006498 |
290 | RESPONSE TO STARVATION | 20 | 154 | 0.000405 | 0.006498 |
291 | NEGATIVE REGULATION OF CELL CYCLE | 42 | 433 | 0.000416 | 0.006651 |
292 | REGULATION OF SECRETION | 61 | 699 | 0.0004338 | 0.006889 |
293 | POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 31 | 289 | 0.0004338 | 0.006889 |
294 | RESPONSE TO NITROGEN COMPOUND | 72 | 859 | 0.0004437 | 0.007002 |
295 | SENSORY ORGAN MORPHOGENESIS | 27 | 239 | 0.000444 | 0.007002 |
296 | REGULATION OF ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLE PROPIONATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY | 6 | 19 | 0.0004476 | 0.007008 |
297 | NEGATIVE REGULATION OF GTPASE ACTIVITY | 9 | 42 | 0.0004488 | 0.007008 |
298 | LENS MORPHOGENESIS IN CAMERA TYPE EYE | 6 | 19 | 0.0004476 | 0.007008 |
299 | REGULATION OF GLUCOSE IMPORT | 11 | 60 | 0.0004543 | 0.00707 |
300 | REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 24 | 203 | 0.0004677 | 0.007254 |
301 | PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 8 | 34 | 0.0004752 | 0.007321 |
302 | ADHERENS JUNCTION ASSEMBLY | 8 | 34 | 0.0004752 | 0.007321 |
303 | NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 42 | 437 | 0.0005025 | 0.007716 |
304 | REGULATION OF OSTEOBLAST DIFFERENTIATION | 16 | 112 | 0.00052 | 0.007958 |
305 | APPENDAGE DEVELOPMENT | 21 | 169 | 0.0005352 | 0.008138 |
306 | LIMB DEVELOPMENT | 21 | 169 | 0.0005352 | 0.008138 |
307 | NEURON PROJECTION GUIDANCE | 24 | 205 | 0.0005395 | 0.008177 |
308 | PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 23 | 193 | 0.0005434 | 0.008209 |
309 | INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 12 | 71 | 0.0005522 | 0.008316 |
310 | POSITIVE REGULATION OF HEART GROWTH | 7 | 27 | 0.0005715 | 0.008551 |
311 | DEVELOPMENTAL INDUCTION | 7 | 27 | 0.0005715 | 0.008551 |
312 | REGULATION OF LIPID METABOLIC PROCESS | 30 | 282 | 0.0006106 | 0.009049 |
313 | INTRACELLULAR LIPID TRANSPORT | 6 | 20 | 0.0006092 | 0.009049 |
314 | REGULATION OF TYROSINE PHOSPHORYLATION OF STAT5 PROTEIN | 6 | 20 | 0.0006092 | 0.009049 |
315 | CELL CELL SIGNALING | 65 | 767 | 0.0006236 | 0.009148 |
316 | REGULATION OF CIRCADIAN RHYTHM | 15 | 103 | 0.0006252 | 0.009148 |
317 | POSITIVE REGULATION OF MAP KINASE ACTIVITY | 24 | 207 | 0.0006208 | 0.009148 |
318 | CARDIAC CONDUCTION | 13 | 82 | 0.0006235 | 0.009148 |
319 | RESPONSE TO STEROID HORMONE | 46 | 497 | 0.000632 | 0.009167 |
320 | REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 26 | 232 | 0.0006338 | 0.009167 |
321 | REGULATION OF ENDOTHELIAL CELL MIGRATION | 16 | 114 | 0.0006344 | 0.009167 |
322 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 26 | 232 | 0.0006338 | 0.009167 |
323 | BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS | 9 | 44 | 0.0006451 | 0.009264 |
324 | MESONEPHRIC TUBULE MORPHOGENESIS | 10 | 53 | 0.0006448 | 0.009264 |
325 | DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 15 | 104 | 0.0006934 | 0.009927 |
326 | REGULATION OF HEART CONTRACTION | 25 | 221 | 0.0006962 | 0.009936 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | PROTEIN KINASE ACTIVITY | 88 | 640 | 4.818e-15 | 4.476e-12 |
2 | KINASE ACTIVITY | 103 | 842 | 5.131e-14 | 2.384e-11 |
3 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 105 | 992 | 2.125e-10 | 6.579e-08 |
4 | ADENYL NUCLEOTIDE BINDING | 143 | 1514 | 3.433e-10 | 7.973e-08 |
5 | MOLECULAR FUNCTION REGULATOR | 128 | 1353 | 2.956e-09 | 5.492e-07 |
6 | RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 37 | 228 | 5.469e-09 | 8.467e-07 |
7 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 115 | 1199 | 9.514e-09 | 1.263e-06 |
8 | TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 20 | 81 | 1.474e-08 | 1.522e-06 |
9 | PROTEIN TYROSINE KINASE ACTIVITY | 31 | 176 | 1.318e-08 | 1.522e-06 |
10 | GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 43 | 303 | 2.067e-08 | 1.904e-06 |
11 | RIBONUCLEOTIDE BINDING | 160 | 1860 | 2.254e-08 | 1.904e-06 |
12 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 55 | 445 | 3.334e-08 | 2.581e-06 |
13 | ZINC ION BINDING | 109 | 1155 | 5.593e-08 | 3.997e-06 |
14 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 16 | 64 | 3.372e-07 | 2.088e-05 |
15 | GROWTH FACTOR BINDING | 23 | 123 | 3.193e-07 | 2.088e-05 |
16 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 66 | 629 | 7.493e-07 | 4.351e-05 |
17 | PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 16 | 70 | 1.245e-06 | 6.801e-05 |
18 | ENZYME BINDING | 142 | 1737 | 2.821e-06 | 0.0001456 |
19 | TRANSITION METAL ION BINDING | 119 | 1400 | 3.171e-06 | 0.0001551 |
20 | CYTOSKELETAL PROTEIN BINDING | 77 | 819 | 6.238e-06 | 0.0002898 |
21 | MACROMOLECULAR COMPLEX BINDING | 117 | 1399 | 8.252e-06 | 0.000365 |
22 | ACTIN BINDING | 44 | 393 | 1.062e-05 | 0.0004483 |
23 | KINASE BINDING | 60 | 606 | 1.455e-05 | 0.0005877 |
24 | CELL ADHESION MOLECULE BINDING | 26 | 186 | 1.641e-05 | 0.0006351 |
25 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 38 | 328 | 1.947e-05 | 0.0007234 |
26 | INTEGRIN BINDING | 18 | 105 | 2.088e-05 | 0.0007462 |
27 | PROTEIN COMPLEX BINDING | 83 | 935 | 2.319e-05 | 0.0007692 |
28 | TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING | 58 | 588 | 2.246e-05 | 0.0007692 |
29 | PROTEIN DOMAIN SPECIFIC BINDING | 60 | 624 | 3.456e-05 | 0.001107 |
30 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING | 20 | 133 | 5.32e-05 | 0.001647 |
31 | STEROID HORMONE RECEPTOR ACTIVITY | 12 | 59 | 8.985e-05 | 0.002693 |
32 | ION CHANNEL BINDING | 17 | 111 | 0.0001504 | 0.004366 |
33 | PHOSPHATIDYLINOSITOL 3 KINASE BINDING | 8 | 30 | 0.0001871 | 0.005268 |
34 | TRANSCRIPTION COACTIVATOR BINDING | 5 | 11 | 0.000193 | 0.005275 |
35 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 34 | 315 | 0.0002089 | 0.005544 |
36 | TRANSCRIPTION FACTOR ACTIVITY DIRECT LIGAND REGULATED SEQUENCE SPECIFIC DNA BINDING | 10 | 48 | 0.0002791 | 0.007067 |
37 | REGULATORY REGION NUCLEIC ACID BINDING | 70 | 818 | 0.0002967 | 0.007067 |
38 | EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT | 13 | 76 | 0.0002915 | 0.007067 |
39 | RECEPTOR BINDING | 114 | 1476 | 0.0002951 | 0.007067 |
40 | DOUBLE STRANDED DNA BINDING | 66 | 764 | 0.0003389 | 0.007872 |
41 | PHOSPHATIDYLINOSITOL BINDING | 24 | 200 | 0.0003756 | 0.008511 |
42 | LIPID BINDING | 58 | 657 | 0.0004473 | 0.009893 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | NEURON PROJECTION | 102 | 942 | 1.093e-10 | 6.384e-08 |
2 | SYNAPSE | 85 | 754 | 6.134e-10 | 1.791e-07 |
3 | NEURON PART | 123 | 1265 | 1.203e-09 | 1.945e-07 |
4 | CELL PROJECTION | 160 | 1786 | 1.332e-09 | 1.945e-07 |
5 | CELL JUNCTION | 112 | 1151 | 6.836e-09 | 7.984e-07 |
6 | POSTSYNAPSE | 49 | 378 | 4.216e-08 | 4.104e-06 |
7 | SYNAPSE PART | 68 | 610 | 5.216e-08 | 4.352e-06 |
8 | CELL PROJECTION PART | 93 | 946 | 8.845e-08 | 6.457e-06 |
9 | SOMATODENDRITIC COMPARTMENT | 70 | 650 | 1.283e-07 | 8.326e-06 |
10 | APICAL JUNCTION COMPLEX | 24 | 128 | 1.687e-07 | 9.853e-06 |
11 | EXCITATORY SYNAPSE | 31 | 197 | 1.906e-07 | 1.012e-05 |
12 | GOLGI APPARATUS | 127 | 1445 | 2.426e-07 | 1.18e-05 |
13 | MEMBRANE REGION | 103 | 1134 | 8.239e-07 | 3.701e-05 |
14 | CELL CELL JUNCTION | 45 | 383 | 2.369e-06 | 9.881e-05 |
15 | PLASMA MEMBRANE REGION | 85 | 929 | 5.921e-06 | 0.0002305 |
16 | CELL CORTEX | 31 | 238 | 1.138e-05 | 0.0004154 |
17 | CYTOPLASMIC REGION | 35 | 287 | 1.375e-05 | 0.0004724 |
18 | MEMBRANE MICRODOMAIN | 34 | 288 | 3.568e-05 | 0.001158 |
19 | PROTEINACEOUS EXTRACELLULAR MATRIX | 39 | 356 | 5.36e-05 | 0.001648 |
20 | FILOPODIUM | 16 | 94 | 6.467e-05 | 0.001888 |
21 | INTRACELLULAR VESICLE | 103 | 1259 | 7.068e-05 | 0.001966 |
22 | CELL LEADING EDGE | 38 | 350 | 8.048e-05 | 0.002065 |
23 | PLASMA MEMBRANE RAFT | 15 | 86 | 8.134e-05 | 0.002065 |
24 | INTRINSIC COMPONENT OF PLASMA MEMBRANE | 128 | 1649 | 9.952e-05 | 0.002325 |
25 | AXON | 43 | 418 | 9.867e-05 | 0.002325 |
26 | VESICLE MEMBRANE | 50 | 512 | 0.0001041 | 0.002339 |
27 | ACTOMYOSIN | 12 | 62 | 0.0001484 | 0.002989 |
28 | CYTOPLASMIC VESICLE PART | 56 | 601 | 0.0001441 | 0.002989 |
29 | DENDRITE | 45 | 451 | 0.0001395 | 0.002989 |
30 | CELL BODY | 48 | 494 | 0.0001601 | 0.003117 |
31 | CELL CELL CONTACT ZONE | 12 | 64 | 0.0002034 | 0.003832 |
32 | CYTOSKELETON | 146 | 1967 | 0.0002553 | 0.004424 |
33 | CELL SURFACE | 66 | 757 | 0.000263 | 0.004424 |
34 | LAMELLIPODIUM | 22 | 172 | 0.0002652 | 0.004424 |
35 | AXON PART | 26 | 219 | 0.0002595 | 0.004424 |
36 | ACTIN FILAMENT BUNDLE | 11 | 57 | 0.0002854 | 0.004629 |
37 | EXTRACELLULAR MATRIX | 42 | 426 | 0.0002961 | 0.004673 |
38 | GOLGI APPARATUS PART | 75 | 893 | 0.0003198 | 0.004915 |
39 | RECYCLING ENDOSOME | 18 | 131 | 0.0003896 | 0.005834 |
40 | RECEPTOR COMPLEX | 34 | 327 | 0.0004179 | 0.006101 |
41 | NEURON SPINE | 17 | 121 | 0.0004301 | 0.006127 |
42 | ANCHORING JUNCTION | 46 | 489 | 0.000446 | 0.006201 |
43 | ACTIN BASED CELL PROJECTION | 22 | 181 | 0.0005422 | 0.007364 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | hsa04144_Endocytosis | 30 | 203 | 1.175e-06 | 0.0001126 | |
2 | hsa04014_Ras_signaling_pathway | 33 | 236 | 1.251e-06 | 0.0001126 | |
3 | hsa04510_Focal_adhesion | 29 | 200 | 2.605e-06 | 0.0001563 | |
4 | hsa04151_PI3K_AKT_signaling_pathway | 41 | 351 | 7.593e-06 | 0.0002804 | |
5 | hsa04010_MAPK_signaling_pathway | 34 | 268 | 7.788e-06 | 0.0002804 | |
6 | hsa04514_Cell_adhesion_molecules_.CAMs. | 20 | 136 | 7.335e-05 | 0.002101 | |
7 | hsa04270_Vascular_smooth_muscle_contraction | 18 | 116 | 8.171e-05 | 0.002101 | |
8 | hsa04720_Long.term_potentiation | 13 | 70 | 0.0001238 | 0.002785 | |
9 | hsa04810_Regulation_of_actin_cytoskeleton | 26 | 214 | 0.0001793 | 0.00346 | |
10 | hsa04710_Circadian_rhythm_._mammal | 7 | 23 | 0.0001922 | 0.00346 | |
11 | hsa04390_Hippo_signaling_pathway | 20 | 154 | 0.000405 | 0.006627 | |
12 | hsa04310_Wnt_signaling_pathway | 19 | 151 | 0.0008273 | 0.01224 | |
13 | hsa04512_ECM.receptor_interaction | 13 | 85 | 0.0008839 | 0.01224 | |
14 | hsa04350_TGF.beta_signaling_pathway | 12 | 85 | 0.002762 | 0.03551 | |
15 | hsa04530_Tight_junction | 16 | 133 | 0.003261 | 0.03913 | |
16 | hsa04912_GnRH_signaling_pathway | 13 | 101 | 0.004276 | 0.04528 | |
17 | hsa04916_Melanogenesis | 13 | 101 | 0.004276 | 0.04528 | |
18 | hsa04910_Insulin_signaling_pathway | 16 | 138 | 0.0047 | 0.047 | |
19 | hsa04360_Axon_guidance | 15 | 130 | 0.006354 | 0.0574 | |
20 | hsa04630_Jak.STAT_signaling_pathway | 17 | 155 | 0.006377 | 0.0574 | |
21 | hsa04971_Gastric_acid_secretion | 10 | 74 | 0.008215 | 0.07041 | |
22 | hsa02010_ABC_transporters | 7 | 44 | 0.01075 | 0.08794 | |
23 | hsa04540_Gap_junction | 11 | 90 | 0.01198 | 0.09374 | |
24 | hsa04340_Hedgehog_signaling_pathway | 8 | 56 | 0.01251 | 0.09379 | |
25 | hsa04920_Adipocytokine_signaling_pathway | 9 | 68 | 0.0135 | 0.0972 | |
26 | hsa04730_Long.term_depression | 9 | 70 | 0.01614 | 0.1117 | |
27 | hsa04666_Fc_gamma_R.mediated_phagocytosis | 11 | 95 | 0.01748 | 0.1165 | |
28 | hsa04150_mTOR_signaling_pathway | 7 | 52 | 0.02552 | 0.1641 | |
29 | hsa04114_Oocyte_meiosis | 12 | 114 | 0.02654 | 0.1648 | |
30 | hsa04070_Phosphatidylinositol_signaling_system | 9 | 78 | 0.03051 | 0.183 | |
31 | hsa04062_Chemokine_signaling_pathway | 17 | 189 | 0.03782 | 0.2196 | |
32 | hsa00562_Inositol_phosphate_metabolism | 7 | 57 | 0.03972 | 0.2234 | |
33 | hsa04520_Adherens_junction | 8 | 73 | 0.05181 | 0.2767 | |
34 | hsa04012_ErbB_signaling_pathway | 9 | 87 | 0.05527 | 0.2767 | |
35 | hsa04914_Progesterone.mediated_oocyte_maturation | 9 | 87 | 0.05527 | 0.2767 | |
36 | hsa00601_Glycosphingolipid_biosynthesis_._lacto_and_neolacto_series | 4 | 26 | 0.05534 | 0.2767 | |
37 | hsa00010_Glycolysis_._Gluconeogenesis | 7 | 65 | 0.07159 | 0.3481 | |
38 | hsa04020_Calcium_signaling_pathway | 15 | 177 | 0.0739 | 0.3481 | |
39 | hsa04664_Fc_epsilon_RI_signaling_pathway | 8 | 79 | 0.07541 | 0.3481 | |
40 | hsa00531_Glycosaminoglycan_degradation | 3 | 19 | 0.08767 | 0.3945 | |
41 | hsa04722_Neurotrophin_signaling_pathway | 11 | 127 | 0.1016 | 0.4397 | |
42 | hsa00640_Propanoate_metabolism | 4 | 32 | 0.1026 | 0.4397 | |
43 | hsa04972_Pancreatic_secretion | 9 | 101 | 0.1144 | 0.4791 | |
44 | hsa04140_Regulation_of_autophagy | 4 | 34 | 0.1214 | 0.4968 | |
45 | hsa04320_Dorso.ventral_axis_formation | 3 | 25 | 0.1633 | 0.639 | |
46 | hsa00500_Starch_and_sucrose_metabolism | 5 | 54 | 0.1855 | 0.7045 | |
47 | hsa04115_p53_signaling_pathway | 6 | 69 | 0.1907 | 0.7045 | |
48 | hsa00052_Galactose_metabolism | 3 | 27 | 0.1918 | 0.7045 | |
49 | hsa03320_PPAR_signaling_pathway | 6 | 70 | 0.1995 | 0.7182 | |
50 | hsa04960_Aldosterone.regulated_sodium_reabsorption | 4 | 42 | 0.2089 | 0.7333 | |
51 | hsa04670_Leukocyte_transendothelial_migration | 9 | 117 | 0.2119 | 0.7333 | |
52 | hsa00071_Fatty_acid_metabolism | 4 | 43 | 0.2209 | 0.734 | |
53 | hsa04962_Vasopressin.regulated_water_reabsorption | 4 | 44 | 0.2331 | 0.734 | |
54 | hsa04210_Apoptosis | 7 | 89 | 0.2334 | 0.734 | |
55 | hsa04970_Salivary_secretion | 7 | 89 | 0.2334 | 0.734 | |
56 | hsa04650_Natural_killer_cell_mediated_cytotoxicity | 10 | 136 | 0.2349 | 0.734 | |
57 | hsa00512_Mucin_type_O.Glycan_biosynthesis | 3 | 30 | 0.2365 | 0.734 | |
58 | hsa04370_VEGF_signaling_pathway | 6 | 76 | 0.2547 | 0.7771 | |
59 | hsa04660_T_cell_receptor_signaling_pathway | 8 | 108 | 0.2614 | 0.7843 | |
60 | hsa00250_Alanine._aspartate_and_glutamate_metabolism | 3 | 32 | 0.2672 | 0.7885 | |
61 | hsa00564_Glycerophospholipid_metabolism | 6 | 80 | 0.2936 | 0.8524 | |
62 | hsa04974_Protein_digestion_and_absorption | 6 | 81 | 0.3035 | 0.8672 | |
63 | hsa00561_Glycerolipid_metabolism | 4 | 50 | 0.3089 | 0.8688 | |
64 | hsa00410_beta.Alanine_metabolism | 2 | 22 | 0.3529 | 0.9773 | |
65 | hsa00600_Sphingolipid_metabolism | 3 | 40 | 0.3921 | 1 | |
66 | hsa00620_Pyruvate_metabolism | 3 | 40 | 0.3921 | 1 | |
67 | hsa04662_B_cell_receptor_signaling_pathway | 5 | 75 | 0.4143 | 1 | |
68 | hsa04260_Cardiac_muscle_contraction | 5 | 77 | 0.4368 | 1 | |
69 | hsa04146_Peroxisome | 5 | 79 | 0.459 | 1 | |
70 | hsa04141_Protein_processing_in_endoplasmic_reticulum | 10 | 168 | 0.4724 | 1 | |
71 | hsa04330_Notch_signaling_pathway | 3 | 47 | 0.4967 | 1 | |
72 | hsa00650_Butanoate_metabolism | 2 | 30 | 0.5087 | 1 | |
73 | hsa00510_N.Glycan_biosynthesis | 3 | 49 | 0.5249 | 1 | |
74 | hsa04672_Intestinal_immune_network_for_IgA_production | 3 | 49 | 0.5249 | 1 | |
75 | hsa00260_Glycine._serine_and_threonine_metabolism | 2 | 32 | 0.5437 | 1 | |
76 | hsa04610_Complement_and_coagulation_cascades | 4 | 69 | 0.5477 | 1 | |
77 | hsa04640_Hematopoietic_cell_lineage | 5 | 88 | 0.5551 | 1 | |
78 | hsa03018_RNA_degradation | 4 | 71 | 0.5706 | 1 | |
79 | hsa04976_Bile_secretion | 4 | 71 | 0.5706 | 1 | |
80 | hsa00330_Arginine_and_proline_metabolism | 3 | 54 | 0.5915 | 1 | |
81 | hsa00565_Ether_lipid_metabolism | 2 | 36 | 0.6084 | 1 | |
82 | hsa04130_SNARE_interactions_in_vesicular_transport | 2 | 36 | 0.6084 | 1 | |
83 | hsa03022_Basal_transcription_factors | 2 | 37 | 0.6234 | 1 | |
84 | hsa04612_Antigen_processing_and_presentation | 4 | 78 | 0.6452 | 1 | |
85 | hsa04145_Phagosome | 8 | 156 | 0.6553 | 1 | |
86 | hsa00380_Tryptophan_metabolism | 2 | 42 | 0.6919 | 1 | |
87 | hsa03015_mRNA_surveillance_pathway | 4 | 83 | 0.6929 | 1 | |
88 | hsa00280_Valine._leucine_and_isoleucine_degradation | 2 | 44 | 0.7163 | 1 | |
89 | hsa00310_Lysine_degradation | 2 | 44 | 0.7163 | 1 | |
90 | hsa04973_Carbohydrate_digestion_and_absorption | 2 | 44 | 0.7163 | 1 | |
91 | hsa04110_Cell_cycle | 6 | 128 | 0.7318 | 1 | |
92 | hsa04380_Osteoclast_differentiation | 6 | 128 | 0.7318 | 1 | |
93 | hsa00520_Amino_sugar_and_nucleotide_sugar_metabolism | 2 | 48 | 0.7601 | 1 | |
94 | hsa04742_Taste_transduction | 2 | 52 | 0.798 | 1 | |
95 | hsa04120_Ubiquitin_mediated_proteolysis | 6 | 139 | 0.7998 | 1 | |
96 | hsa00140_Steroid_hormone_biosynthesis | 2 | 57 | 0.8378 | 1 | |
97 | hsa04142_Lysosome | 4 | 121 | 0.9141 | 1 | |
98 | hsa00980_Metabolism_of_xenobiotics_by_cytochrome_P450 | 2 | 71 | 0.9143 | 1 | |
99 | hsa04622_RIG.I.like_receptor_signaling_pathway | 2 | 71 | 0.9143 | 1 | |
100 | hsa00240_Pyrimidine_metabolism | 3 | 99 | 0.922 | 1 | |
101 | hsa00230_Purine_metabolism | 5 | 162 | 0.9536 | 1 | |
102 | hsa04620_Toll.like_receptor_signaling_pathway | 2 | 102 | 0.9808 | 1 | |
103 | hsa03013_RNA_transport | 3 | 152 | 0.9924 | 1 | |
104 | hsa04740_Olfactory_transduction | 4 | 388 | 1 | 1 |